Details of the Optogenetic System
General Information of This Optogenetic System (OS) | ||||||
---|---|---|---|---|---|---|
OS ID |
OS00628
|
|||||
OS Name |
Optogenetic dopamine transporter multimerization system
(OptoDTM)
|
[1] | ||||
Photoreceptor (PR) |
|
|||||
Complementary Protein | Cryptochrome-interacting basic-helix-loop-helix 1 (CIB1/CIBN) | |||||
Cofactor | Flavin adenine dinucleotide (FAD) | |||||
Controlled Protein | Fusion protein | Sodium-dependent dopamine transporter | ||||
OS Application Information (1) | ||||||
---|---|---|---|---|---|---|
Mechanism of Action | CRY2 oligomerization | [ 1] | ||||
Controlled Signal Pathway | Dopamine transportation | |||||
Effect | Activation | |||||
Application | Test the functional importance of DAT multimerization in both the absence and pressence of ligands for DAT | |||||
Note | DAT multimers may function to help maitain DA homeostasis | |||||
Light Information | Activation Wavelength | 488 nm | ||||
Process | Reversible | |||||
Deactivation Wavelength | Dark | |||||
Activation Time | 30 s | |||||
Deactivation Time | Minutes | |||||
Light Intensity | 13 microwatts | |||||
Expression Information | Expression Method | Transfection | ||||
Cell Lines | HEK293 cells | |||||